Researchers believe that this is consistent with the model of SN as an endogenous CaMKII inhibitor, where overstimulation leads to arrhythmogenic calcium release, as the risk of new ventricular arrhythmia events is highest in the early post-hospital period. Here, CAMK2G is linked to Ventricular arrhythmia.